STACIE STAUFFER: Open Payments
NPI 1477055804 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,577 in 124 payments from 15 companies in 2025. Trend: 2023 $955 · 2024 $1,938 · 2025 $2,577
Food & beverage: $2,577
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $511 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $462 |
| ABBVIE INC. | 41 | $432 |
| Madrigal Pharmaceuticals | 8 | $322 |
| Gilead Sciences, Inc. | 6 | $187 |
| GENZYME CORPORATION | 5 | $117 |
| Pharmacosmos Therapeutics Inc. | 1 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $96 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| QOL Medical, LLC | 5 | $87 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, DUPIXENT, LINZESS, RINVOQ, EOHILIA, Livdelzi.
Industry payments across IN — which companies pay providers there.
